Tadalafil Mylan 20 mg film-coated tablets EFG
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: information for the patient
Tadalafilo Mylan 20 mg film-coated tablets EFG
tadalafil
Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.
-
Keep this leaflet, as you may need to read it again.
-
If you have any questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
-
If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.
Contents of the leaflet
- What Tadalafilo Mylan is and what it is used for
- What you need to know before taking Tadalafilo Mylan
- How to take Tadalafilo Mylan
- Possible side effects
- How to store Tadalafilo Mylan
- Contents of the pack and other information
1. What is Tadalafil Mylan and what is it used for
Tadalafil Mylan is indicated for the treatment of erectile dysfunction in adult men. Erectile dysfunction occurs when a man is unable to achieve or maintain a firm erection suitable for satisfactory sexual activity. Tadalafil Mylan has demonstrated significant improvement in the ability to achieve a durable penile erection suitable for sexual activity.
Tadalafil Mylan contains the active substance tadalafil, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors. Following sexual stimulation, Tadalafil Mylan works by helping to relax the blood vessels in the penis, allowing blood to flow into the penis. The result is improved erectile function. Tadalafil Mylan will not help you if you do not have erectile dysfunction.
It is important to warn you that Tadalafil Mylan is not effective in the absence of sexual stimulation. Therefore, you and your partner should engage in the same kind of stimulation as you would if you were not taking a medicine for erectile dysfunction.
2. What you need to know before taking Tadalafilo Mylan
Do not take Tadalafilo Mylan
-
if you are allergic to tadalafil or to any of the other ingredients of this medicine (listed in section 6).
-
if you are taking any type of organic nitrates or nitric oxide donors such as amyl nitrite. This is a group of medicines (“nitrates”) used to treat angina pectoris (“chest pain”). Tadalafilo Mylan has been shown to increase the effects of these medicines. If you are taking any type of nitrate or are unsure, tell your doctor.
-
if you have a severe heart condition or have recently had a heart attack (within the last 90 days).
-
if you have had a stroke within the last 6 months.
-
if you have low blood pressure or uncontrolled high blood pressure.
-
if you have ever experienced sudden vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION), a condition described as “stroke of the eye”.
-
if you are taking riociguat. This medicine is used to treat pulmonary arterial hypertension (i.e., high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e., high blood pressure in the lungs caused by blood clots). PDE5 inhibitors, such as Tadalafilo Mylan, have been shown to increase the hypotensive effect of this medicine. If you are taking riociguat or are unsure, consult your doctor.
Warnings and precautions
Talk to your doctor before starting to take Tadalafilo Mylan.
Be aware that sexual activity carries a potential risk for patients with heart problems, due to the additional strain placed on the heart. If you have a heart condition, consult your doctor.
Before taking the tablets, inform your doctor if you have:
- sickle cell anemia (an abnormality of red blood cells).
- multiple myeloma (a cancer of the bone marrow).
- leukemia (a cancer of blood cells).
- any deformity of the penis.
- severe liver problems.
- severe kidney problems.
It is not known whether Tadalafilo Mylan is effective in patients who have undergone:
- surgery in the pelvic area.
- a surgical procedure in which the prostate was completely or partially removed and the nerves to the prostate were cut (radical prostatectomy without neurovascular bundle preservation).
If you experience sudden decrease or loss of vision, stop taking Tadalafilo Mylan and contact your doctor immediately.
Sudden decrease or loss of hearing has been reported in some patients taking tadalafil. Although it is not known whether the event is directly related to tadalafil, if you experience sudden decrease or loss of hearing, stop treatment with Tadalafilo Mylan and contact your doctor immediately.
Tadalafilo Mylan is not intended for use in women.
Children and adolescents
Tadalafilo Mylan must not be used in children or adolescents under 18 years of age.
Other medicines and Tadalafilo Mylan
Tell your doctor or pharmacist if you are using, have recently used, or might need to use any other medicines.
Do not take Tadalafilo Mylan if you are already using nitrates.
Some medicines may be affected by Tadalafilo Mylan or may affect how well Tadalafilo Mylan works. Inform your doctor or pharmacist if you are taking:
-
an alpha-blocker (used to treat high blood pressure or urinary symptoms associated with benign prostatic hyperplasia).
-
other medicines for treating high blood pressure.
-
riociguat.
-
a 5-alpha reductase inhibitor (used to treat benign prostatic hyperplasia).
-
medicines such as ketoconazole tablets (for treatment of fungal infections) and protease inhibitors for treatment of AIDS or HIV infection.
-
phenobarbital, phenytoin, and carbamazepine (anticonvulsant medicines).
-
rifampicin, erythromycin, clarithromycin, or itraconazole.
-
other treatments for erectile dysfunction.
Taking Tadalafilo Mylan with food and alcohol
Grapefruit juice may affect how well Tadalafilo Mylan works and should be taken with caution. Consult your doctor for further information.
Drinking alcohol may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafilo Mylan, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as this may increase the risk of dizziness upon standing.
Fertility
In dogs treated with tadalafil, a decrease in sperm production by the testes was observed. A reduction in sperm count has been observed in some men. These effects are unlikely to result in infertility.
Driving and using machines
Some men who took Tadalafilo Mylan during clinical trials experienced dizziness. Carefully assess how you react when taking the tablets before driving or operating machinery.
Tadalafilo Mylan contains lactose
If your doctor has informed you of an intolerance to certain sugars, contact him or her before taking this medicine.
Tadalafilo Mylan contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; hence, it is essentially “sodium-free”.
3. How to take Tadalafil Mylan
Follow exactly the instructions for use of this medicine provided by your doctor.
If in doubt, consult your doctor or pharmacist again.
The recommended starting dose is one 10 mg tablet prior to sexual activity. However, you have been given a dose of one 20 mg tablet because your doctor has decided that the recommended 10 mg dose is too weak for you.
When you take Tadalafil Mylan, you may initiate sexual activity at least 30 minutes after taking the tablet.
Tadalafil Mylan may remain effective up to 36 hours after taking the tablet.
You must not take Tadalafil Mylan more than once a day. Tadalafil Mylan 10 mg and 20 mg are intended to be used prior to anticipated sexual activity and are not recommended for continuous daily use.
Tadalafil Mylan tablets are for oral use only in men. Swallow the tablet whole with a little water. The tablets may be taken with or without food.
If you take more Tadalafil Mylan than you should
Consult your doctor. You may experience adverse effects described in section 4.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, Tadalafilo Mylan may cause adverse effects, although not everyone experiences them. These effects are usually mild to moderate in intensity.
If you experience any of the following adverse effects, stop using the medicine and seek immediate medical help:
- allergic reactions including rashes (uncommon).
- chest pain – do not use nitrates, but seek immediate medical help (uncommon).
- priapism, a prolonged and possibly painful erection after taking tadalafil (rare frequency). If you experience this type of erection, which may last continuously for more than 4 hours, you must contact a doctor immediately.
- sudden loss of vision (rare frequency).
Other adverse effects reported:
Frequent (may affect up to 1 in 10 people)
- headache, back pain, muscle aches, pain in arms and legs, facial flushing, nasal congestion, and indigestion.
Uncommon (may affect up to 1 in 100 people)
- dizziness, stomach pain, nausea, vomiting, reflux, blurred vision, eye pain, difficulty breathing, presence of blood in urine, prolonged erection, palpitations, rapid pulse, high blood pressure, low blood pressure, nosebleeds, tinnitus (ringing in the ears), swelling of the hands, feet or ankles, and feeling tired.
Rare (may affect up to 1 in 1000 people)
- fainting, seizures, transient memory loss, eyelid swelling, red eyes, sudden decrease or loss of hearing, urticaria (red, itchy welts on the skin), bleeding from the penis, presence of blood in semen, and increased sweating.
Myocardial infarction (heart attack) and stroke have also been rarely reported in men taking Tadalafilo Mylan. Most of these men had pre-existing heart problems before taking this medicine.
Rare cases of partial, transient or permanent decrease or loss of vision in one or both eyes have also been reported.
Some additional rare adverse effects have been reported in men taking Tadalafilo Mylan that were not observed during clinical trials. These include:
- migraine, facial swelling, severe allergic reaction causing swelling of the face or throat, severe skin rashes, certain disorders affecting blood flow to the eyes, irregular heartbeats, angina pectoris, and sudden cardiac death.
The most frequently reported adverse effect in men over 75 years of age taking Tadalafilo Mylan has been dizziness. Cases of diarrhea were more frequently reported in patients over 65 years of age taking Tadalafilo Mylan.
Reporting of adverse effects
If you experience any adverse effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Tadalafil Mylan
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after “CAD” and “EXP”, respectively. The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines and packaging when they are no longer needed. This will help protect the environment.
6. Contents of the pack and other information
Composition of Tadalafil Mylan
- The active substance is tadalafil. Each tablet contains 20 mg of tadalafil.
- The other components are:
Tablet core: anhydrous lactose (see section 2 “Tadalafil Mylan contains lactose”), poloxamer 188, microcrystalline cellulose (pH101), povidone (K-25), sodium croscarmellose, magnesium stearate, sodium lauryl sulfate, colloidal anhydrous silica.
Film coating: lactose monohydrate, hypromellose (E464), titanium dioxide (E171), yellow iron oxide (E172), triacetin.
Appearance of the product and contents of the pack
Tadalafil Mylan 20 mg is a light yellow, film-coated, round, biconvex tablet, marked with an “M” on one side and “TL4” on the other.
Tadalafil Mylan 20 mg is available in blister packs containing 2, 4, 8, 12 and 24 tablets.
Only certain pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Mylan S.A.S.
117 Allée des Parcs
69800 Saint-Priest
France
Manufacturer
McDermott Laboratories Ltd. trading as Gerard Laboratories
35/36 Baldoyle Industrial Estate, Grange Road
Dublin 13
Ireland
Mylan Hungary Kft.
Mylan utca 1
Komárom, 2900
Hungary
Generics [UK] Limited
Station Close
Potters Bar, EN6 1TL
United Kingdom
Mylan UK Healthcare Limited
Building 20, Station Close
Potters Bar, EN6 1TL
United Kingdom
Mylan Germany GmbH
Zweigniederlassung Bad Homburg v. d. Hoehe, Benzstrasse 1
Bad Homburg v. d. Hoehe
Hessen, 61352
Germany
For further information about this medicinal product, please contact the local representative of the Marketing Authorization Holder.
Belgium/Belgium/Belgium Mylan bvba/sprl Tél/Tel: + 32 (0)2 658 61 00 | Lithuania BGP Products UAB Tel: + 370 5 205 1288 |
Bulgaria BGP Products Bulgaria EOOD Tel: + 359 2 44 55 400 | Luxembourg/Luxembourg Mylan bvba/sprl Tel: + 32 (0)2 658 61 00 (Belgium/Belgium) |
Czech Republic Mylan Healthcare CZ s.r.o. Tel: + 420 222 004 400 | Hungary Mylan EPD Kft. Tel: + 36 1 465 2100 |
Denmark Mylan Denmark ApS Tel: + 45 28 11 69 32 | Malta V.J. Salomone Pharma Ltd Tel: + 356 21 22 01 74 |
Germany Mylan Healthcare GmbH Tel: + 49 800 0700 800 | Netherlands Mylan BV Tel: + 31 (0)20 426 3300 |
Estonia BGP Products Switzerland GmbH Estonia branch Tel: + 372 6363 052 | Norway Mylan Healthcare Norge AS Tel: + 47 66 75 33 00 |
Greece Generics Pharma Hellas EPE Tel: + 30 210 993 6410 | Austria Arcana Arzneimittel GmbH Tel: + 43 1 416 2418 |
Spain Mylan Pharmaceuticals, S.L. Tel: + 34 900 102 712 | Poland Mylan Healthcare Sp. z o.o. Tel: + 48 22 546 64 00 |
France Mylan S.A.S Tel: + 33 4 37 25 75 00 | Portugal Mylan, Lda. Tel: + 351 21 412 72 56 |
Croatia Mylan Hrvatska d.o.o. Tel: + 385 1 23 50 599 | Romania BGP Products SRL Tel: + 40 372 579 000 |
Ireland Mylan Ireland Limited Tel: + 353 (0) 87 1694982 | Slovenia Mylan Healthcare d.o.o. Tel: + 386 1 23 63 180 |
Iceland Icepharma hf Tel: + 354 540 8000 | Slovakia Mylan s.r.o. Tel: + 421 2 32 199 100 |
Italy Mylan Italia S.r.l. Tel: + 39 02 612 46921 | Finland Mylan Finland OY Puh/Tel: + 358 20 720 9555 |
Cyprus Varnavas Hadjipanayis Ltd Tel: + 357 222 077 23 | Sweden Mylan AB Tel: + 46 855 522 750 |
Latvia Mylan Healthcare SIA Tel: + 371 676 05580 | United Kingdom Generics [UK] Ltd. Tel: + 44 1707 853000 |
Date of the most recent review of this leaflet:
Other sources of information
Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.euopa.eu and on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS, http://www.aemps.gob.es/).